Scharen-Guivel Hilda Frederique

Track

Insider profile

Performance

Overall performance
Performance over holding periods
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Scharen-Guivel Hilda Frederique's trades of IRadimed Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US IRadimed Corp (IRMD)
Transaction date
Sale
Price
183.28
Quantity 17,265 +39.1%
Value US$1,794,886
US IRadimed Corp (IRMD)
Transaction date
Sale
Price
489.97
Quantity 27,972 -20.5%
Value US$485,442
US IRadimed Corp (IRMD)
Transaction date
Proposed sale
Price
429.99
Quantity 77,920
Value US$2,466,403
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-04 2026-06-04
US IRadimed Corp (IRMD)
S Sale
17,265 +39.1%
183.28
US$1,794,886 		17,265 +39.1% 183.28 US$1,794,886
2026-06-04 2026-06-04
US IRadimed Corp (IRMD)
S Sale
27,972 -20.5%
489.97
US$485,442 		27,972 -20.5% 489.97 US$485,442
2026-06-04 2026-06-04
US IRadimed Corp (IRMD)
PrS Proposed sale
77,920
429.99
US$2,466,403 		77,920 429.99 US$2,466,403